Kehua Bio: The self-developed new crown detection kit has obtained EU CE certification and is shortlisted for export whitelist.

Some investors asked questions on the investor interactive platform: Hello, leader! Is your company’s new crown detection agent the main business of the company or a subsidiary of Tianlong? In addition, is the certificate exported to Europe, America and other countries obtained by Tianlong subsidiary or by the company? In terms of detection technology, is the company leading or Tianlong subsidiary leading? Please reply to these three questions in detail, thank you!

　　Kehua Bio(002022.SZ) stated on the investor interaction platform on January 15 that the main business of the parent company mainly involves instruments and reagents in the fields of biochemical diagnosis, immunodiagnosis, and molecular diagnosis;Kehua BioThe self-developed COVID-19 detection kit obtained EU CE certification and was shortlisted for export. The products of the subsidiary Tianlong Company are mainly based on molecular diagnosis, which can be widely used in the detection of new crowns. It mainly focuses on the domestic market, and also deploys overseas business. The Italian subsidiary TGS also has self-developed new crown detection products to serve the anti-epidemic in Italy and its surrounding areas.

(Article source: Daily Economic News)

Article source: Daily Economic News

Responsible editor: 65

Original title: Kehua Bio: The self-developed new crown detection kit obtained EU CE certification and was shortlisted for export whitelist